Expression of C5a in the brain does not exacerbate experimental autoimmune encephalomyelitis

Neuroscience Letters

Volumn 390, Issue 3, 2005, Pages 134-138

  Reiman, Rachael ^a   Torres, Antonio Campos ^a   Martin, Brian K ^b   Ting, Jenny P ^c   Campbell, Iain L ^d   Barnum, Scott R ^a,e  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SYDNEY   (Australia)

^e The University of Alabama at Birmingham   (United States)

Author keywords

Anaphylatoxins; Complement; Neuroimmunology; Transgenic mice

Indexed keywords

COMPLEMENT COMPONENT C5A; GLIAL FIBRILLARY ACIDIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DISEASE SEVERITY; INFLAMMATION; MOUSE; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEWBORN; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; BRAIN; COMPLEMENT C5A; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEINS; HUMANS; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; SEVERITY OF ILLNESS INDEX;

EID: 26944477028     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.08.022     Document Type: Article

References (44)

1. H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, G.M. Cole, N.R. Cooper, P. Eikelenboom, M. Emmerling, B.L. Fiebich, C.E. Finch, S. Frautschy, W.S. Griffin, H. Hampel, M. Hull, G. Landreth, L. Lue, R. Mrak, I.R. Mackenzie, P.L. McGeer, M.K. O'Banion, J. Pachter, G. Pasinetti, C. Plata-Salaman, J. Rogers, R. Rydel, Y. Shen, W. Streit, R. Strohmeyer, I. Tooyoma, F.L. Van Muiswinkel, R. Veerhuis, D. Walker, S. Webster, B. Wegrzyniak, G. Wenk, and T. Wyss-Coray Inflammation and Alzheimer's disease Neurobiol. Aging 21 2000 383 421
2. T.V. Arumugam, I.A. Shiels, T.M. Woodruff, D.N. Granger, and S.M. Taylor The role of the complement system in ischemia-reperfusion injury Shock 21 2004 401 409
3. T.V. Arumugam, T.M. Woodruff, S.Z. Stocks, L.M. Proctor, S. Pollitt, I.A. Shiels, R.C. Reid, D.P. Fairlie, and S.M. Taylor Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats J. Hepatol. 40 2004 934 941
4. S.R. Barnum The complement system in demyleinating disease: new insights from transgenic and complement-deficient mice S.C. Bondy A. Campbell Inflammatory Events in Neurodegeneration 2001 Prominent Press Scottsdale 139 156
5. S.R. Barnum Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease Mol. Med. 5 1999 569 582
6. S.R. Barnum, R.S. Ames, P.R. Maycox, S.J. Hadingham, J. Meakin, D. Harrison, and A.A. Parsons Expression of the complement C3a and C5a receptors after permanent focal ischemia: an alternative interpretation Glia 38 2002 169 173
7. C.C. Bernard, T.G. Johns, A. Slavin, M. Ichikawa, C. Ewing, J. Liu, and J. Bettadapura Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis J. Mol. Med. 75 1997 77 88
8. L. Boos, I.L. Campbell, R. Ames, R.A. Wetsel, and S.R. Barnum Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis J. Immunol. 173 2004 4708 4714
9. L. Boos, A.J. Szalai, and S.R. Barnum C3a expressed in the central nervous system protects against LPS-induced shock Neurosci. Lett. 387 2005 68 71
10. I.L. Campbell, C.R. Abraham, E. Masliah, P. Kemper, J.D. Inglis, M.B. Oldstone, and L. Mucke Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6 Proc. Natl. Acad. Sci. U.S.A. 90 1993 10061 10065
11. C.S. Chiang, H.C. Powell, L.H. Gold, A. Samimi, and I.L. Campbell Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice J. Clin. Invest. 97 1996 1512 1524
12. N. Davoust, S. Nataf, V.M. Holers, and S.R. Barnum Expression of the murine complement regulatory protein crry by glial cells and neurons Glia 27 1999 162 170
13. B. de Vries, J. Kohl, W.K. Leclercq, T.G. Wolfs, A.A. van Bijnen, P. Heeringa, and W.A. Buurman Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils J. Immunol. 170 2003 3883 3889
14. B. De Vries, R.A. Matthijsen, T.G. Wolfs, A.A. Van Bijnen, P. Heeringa, and W.A. Buurman Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation Transplantation 75 2003 375 382
15. J.A. Ember, M.A. Jagels, and T.E. Hugli Characterization of complement anaphylatoxina and their biological responses J.E. Volanakis M.M. Frank The Human Complement System in Health and Disease 1998 Marcel Dekker Inc. New York 241 284
16. I. Farkas, L. Baranyi, Z.S. Liposits, T. Yamamoto, and H. Okada Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells Neuroscience 86 1998 903 911
17. I. Farkas, L. Baranyi, M. Takahashi, A. Fukuda, Z. Liposits, T. Yamamoto, and H. Okada A neuronal C5a receptor and an associated apoptotic signal transduction pathway J. Physiol. (Lond.) 507 1998 679 687
18. P.M. Faustmann, D. Krause, R. Dux, and R. Dermietzel Morphological study in the early stages of complement C5a fragment-induced experimental meningitis: activation of macrophages and astrocytes Acta Neuropathol. 89 1995 239 247
19. P. Gasque, Y.D. Dean, E.P. McGreal, J. VanBeek, and B.P. Morgan Complement components of the innate immune system in health and disease in the CNS Immunopharmacology 49 2000 171 186
20. P. Gasque, S.K. Singhrao, J.W. Neal, O. Gotze, and B.P. Morgan Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system Am. J. Pathol. 150 1997 31 41
21. R.F. Guo, N.C. Riedemann, and P.A. Ward Role of C5a-C5aR interaction in sepsis Shock 21 2004 1 7
22. D.W. Harkin, A. Romaschin, S.M. Taylor, B.B. Rubin, and T.F. Lindsay Complement C5a receptor antagonist attenuates multiple organ injury in a model of ruptured abdominal aortic aneurysm J. Vasc. Surg. 39 2004 196 206
23. J.D. Lambris, and V.M. Holers Therapeutic Interventions in the Complement System first ed. 2000 Humana Press p. 259
24. C. Lucchinetti, W. Bruck, J. Parisi, B. Scheithauer, M. Rodriguez, and H. Lassmann Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination Ann. Neurol. 47 2000 707 717
25. S.C. Makrides Therapeutic inhibition of the complement system Pharmacol. Rev. 50 1998 59 87
26. B.P. Morgan, M. Griffiths, H. Khanom, S.M. Taylor, and J.W. Neal Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats Clin. Exp. Immunol. 138 2004 430 438
27. P. Mukherjee, and G.M. Pasinetti Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3 J. Neurochem. 77 2001 43 49
28. S. Nataf, N. Davoust, R.S. Ames, S.R. Barnum, and Human T cells express the C5a receptor and are chemoattracted to C5a J. Immunol. 162 1999 4018 4123
29. S. Nataf, N. Davoust, and S.R. Barnum Kinetics of anaphylatoxin C5a receptor expression during experimental allergic encephalomyelitis J. Neuroimmunol. 91 1998 147 155
30. S. Nataf, P.F. Stahel, N. Davoust, and S.R. Barnum Complement anaphylatoxin receptors on neurons: new tricks for old receptors? Trends Neurosci. 22 1999 397 402
31. H. Osaka, P. Mukherjee, P.S. Aisen, and G.M. Pasinetti Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity J. Cell Biochem. 73 1999 303 311
32. L.M. Proctor, T.V. Arumugam, I. Shiels, R.C. Reid, D.P. Fairlie, and S.M. Taylor Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury Br. J. Pharmacol. 142 2004 756 764
33. R. Reiman, C. Gerard, I.L. Campbell, and S.R. Barnum Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis Eur. J. Immunol. 32 2002 1157 1163
34. R. Reiman, A. Szalai, S. Barnum, unpublished observations.
35. O.I. Schmidt, M. Infanger, C.E. Heyde, W. Ertel, and P.F. Stahel The role of neuroinflammation in traumatic brain injury Eur. J. Trauma 30 2004 135 149
36. N. Schupf, C.A. Williams, A. Berkman, W.S. Cattell, and L. Kerper Binding specificity and presynaptic action of anaphylatoxin C5a in rat brain Brain Behav. Immun. 3 1989 28 38
37. P.F. Stahel, and S.R. Barnum Bacterial meningitis: complement gene expression in the central nervous system Immunopharmacology 38 1997 65 72
38. P.F. Stahel, K. Frei, H.P. Eugster, A. Fontana, K.M. Hummel, R.A. Wetsel, R.S. Ames, and S.R. Barnum TNF-alpha-mediated expression of the receptor for anaphylatoxin C5a on neurons in experimental Listeria meningoencephalitis J. Immunol. 159 1997 861 869
39. A.K. Stalder, M.J. Carson, A. Pagenstecher, V.C. Asensio, C. Kincaid, M. Benedict, H.C. Powell, E. Masliah, and I.L. Campbell Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor Am. J. Pathol. 153 1998 767 783
40. J. Van Beek, M. Bernaudin, E. Petit, P. Gasque, A. Nouvelot, E.T. MacKenzie, and M. Fontaine Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse Exp. Neurol. 161 2000 373 382
41. J. van Beek, K. Elward, and P. Gasque Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection Ann. N.Y. Acad. Sci. 992 2003 56 71
42. J. Wang, V.C. Asensio, and I.L. Campbell Cytokines and chemokines as mediators of protection and injury in the central nervous system assessed in transgenic mice Curr. Top. Microbiol. Immunol. 265 2002 23 48
43. P.A. Ward The dark side of C5a in sepsis Nat. Rev. Immunol. 4 2004 133 142
44. C.A. Williams, N. Schupf, and T.E. Hugli Anaphylatoxin C5a modulation of an alpha-adrenergic receptor system in the rat hypothalamus J. Neuroimmunol. 9 1985 29 40